Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Cited by (1,002)

Items 601–700 of 1,002

1. A Novel Microfluidic Cell Co-culture Platform for the Study of the Molecular Mechanisms of Parkinson's Disease and Other Synucleinopathies
   João Tiago S. Fernandes, Oldriska Chutna, Virginia Chu, João Pedro Conde, Tiago F. Outeiro · 2016 · Frontiers in Neuroscience
2. The neuropathology of multiple system atrophy and its therapeutic implications
   Elvira Valera, Eliezer Masliah · 2017 · Autonomic Neuroscience
3. Entanglement of Genetics and Epigenetics in Parkinson’s Disease
   Hendrikus J. van Heesbeen, Marten P. Smidt · 2019 · Frontiers in Neuroscience
4. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
   Deirdre B. Hoban, Shelby Shrigley, Bengt Mattsson, Ludivine S. Breger, Ulla Jarl, Tiago Cardoso, Jenny Nelander Wahlestedt, Kelvin C. Luk, Anders Björklund, Malin Parmar · 2020 · Proceedings of the National Academy of Sciences
5. Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease
   Peter A. Barbuti, Roger A. Barker, Patrik Brundin, Serge Przedborski, Stella M. Papa, Lorraine V. Kalia, Hideki Mochizuki · 2021 · Movement Disorders
6. Neuronal cell replacement in Parkinson’s disease
   Eva Hedlund, Thomas Perlmann · 2009 · Journal of Internal Medicine
7. Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain
   Roger A. Barker, Inez de Beaufort · 2013 · Progress in Neurobiology
8. Immunohistochemical Toolkit for Tracking and Quantifying Xenotransplanted Human Stem Cells
   Justine Allard, Ké Li, Xavier Moles Lopez, Stéphane Blanchard, Paul Barbot, Sandrine Rorive, Christine Decaestecker, Roland Pochet, Delphine Bohl, Angelo C. Lepore et al. · 2014 · Regenerative Medicine
9. Neuronal degeneration in striatal transplants and Huntington's disease: potential mechanisms and clinical implications
   Francesca Cicchetti, Denis Soulet, T. B. Freeman · 2011 · Brain
10. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
    Mathieu Bourdenx, Aurélien Nioche, Sandra Doveró, Marie-Laure Arotçarena, Sandrine M. J. Camus, Grégory Porras, Marie-Laure Thiolat, Nicolas P. Rougier, Annick Prigent, Philippe Aubert et al. · 2020 · Science Advances
11. Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson's disease
    Morais, Lívia H., Hara, Daniela B., Bicca, Maíra A., Poli, Anicleto, Takahashi, Reinaldo N. · 2018 · Behavioural Pharmacology
12. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
    Hiroaki Sekiya, Asato Tsuji, Yuki Hashimoto, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson et al. · 2022 · Acta Neuropathologica Communications
13. Challenges in the clinical advancement of cell therapies for Parkinson’s disease
    Sophie Skidmore, Roger A. Barker · 2023 · Nature Biomedical Engineering
14. Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
    Marc Carceles‐Cordon, Dan Weintraub, Alice S. Chen‐Plotkin · 2023 · Neuron
15. Spreading of a Prion Domain from Cell-to-Cell by Vesicular Transport in Caenorhabditis elegans
    Carmen I. Nussbaum-Krammer, Kyung-Won Park, Liming Li, Ronald Melki, Richard I. Morimoto · 2013 · PLoS Genetics
16. Restorative approaches in Parkinson's Disease: Which cell type wins the race?
    Anne K. Meyer, Martina Maisel, Andreas Hermann, Katja Stirl, Alexander Storch · 2009 · Journal of the Neurological Sciences
17. Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes
    Jakob Domert, Christopher Sackmann, Emelie Severinsson, Lotta Agholme, Joakim J. E. Bergström, Martin Ingelsson, Martin Hallbeck · 2016 · PLoS ONE
18. The Oligomer Hypothesis in α-Synucleinopathy
    Kenjiro Ono · 2017 · Neurochemical Research
19. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
    Akio Mori, Yuzuru Imai, Nobutaka Hattori · 2020 · International Journal of Molecular Sciences
20. Rapid macropinocytic transfer of α-synuclein to lysosomes
    Bayati, Armin, Banks, Emily, Han, Chanshuai, Luo, Wen, Reintsch, Wolfgang E., Zorca, Cornelia E., Shlaifer, Irina, Del Cid Pellitero, Esther, Vanderperre, Benoit, McBride, Heidi M. et al. · 2022 · Cell Reports
21. Molecular mechanisms of the co‐deposition of multiple pathological proteins in neurodegenerative diseases
    Takashi Nonaka, Masami Masuda‐Suzukake, Masato Hasegawa · 2017 · Neuropathology
22. The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
    Alexia Polissidis, Lilian Petropoulou-Vathi, Modestos Nakos‐Bimpos, Hardy J. Rideout · 2020 · Biomolecules
23. The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
    Torsten Falk, Robert Tomas Gonzalez, Scott J. Sherman · 2010 · International Journal of Molecular Sciences
24. Emerging therapies for Parkinsonʼs disease
    Werner H Poewe, Philipp Mahlknecht, Joseph J. Jankovic · 2012 · Current Opinion in Neurology
25. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
    Laxmikant G. Gadhe, Arunima Sakunthala, Semanti Mukherjee, Nitisha Gahlot, Riya Bera, Ajay Singh Sawner, Pradeep Kadu, Samir Kumar Maji · 2021 · Biophysical Chemistry
26. Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals
    Toshiro Kanazawa, Eijiro Adachi, Satoshi Orimo, Ayako Nakamura, Hidehiro Mizusawa, Toshiki Uchihara · 2011 · Brain Pathology
27. Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease
    Mélanie Bourque, Marc Morissette, Mélissa Côté, Denis Soulet, Thérèse Di Paolo · 2012 · Neurobiology of Aging
28. .ALPHA.-Synuclein Aggregation and Transmission Are Enhanced by Leucine-Rich Repeat Kinase 2 in Human Neuroblastoma SH-SY5Y Cells
    Kazunari Kondo, Saemi Obitsu, Reiko Teshima · 2011 · Biological and Pharmaceutical Bulletin
29. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice
    Yi-Fang Cui, Gunnar Hargus, Jin-Chong Xu, Janinne Sylvie Schmid, Yan-Qin Shen, Markus Glatzel, Melitta Schachner, Christian Bernreuther · 2009 · Brain
30. Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
    Abid Oueslati, Methodios Ximerakis, Kostas Vekrellis · 2014 · Experimental Neurobiology
31. Primary cilia and autophagic dysfunction in Huntington’s disease
    Kaliszewski, M, Knott, A B, Bossy-Wetzel, E · 2015 · Cell Death & Differentiation
32. Appendectomy may delay P arkinson's disease Onset
    Alexandre Mendes, Alexandra Gonçalves, Nuno Vila‐Chã, Ines C. Moreira, Joana Fernandes, Joana Damásio, Armando M Teixeira-Pinto, Ricardo Jorge Ferreira Taipa, António Bastos Lima, Sara Cavaco · 2015 · Movement Disorders
33. Adult human neural stem cell therapeutics: Current developmental status and prospect
    Hyun Nam · 2015 · World Journal of Stem Cells
34. Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy
    Qidi Hu, Xiangpeng Ren, Ya Liu, Zhihui Li, Liping Zhang, Xingjun Chen, Chaoxiang He, Jiang‐Fan Chen · 2016 · Experimental Neurology
35. Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach
    Mattia Toni, Maria Lina Massimino, Agnese De Mario, Elisa Angiulli, Enzo Spisni · 2017 · Frontiers in Neuroscience
36. Treating Parkinson’s Disease with Antibodies: Previous Studies and Future Directions
    Anne-Marie Castonguay, Claude Gravel, Martin Lévesque · 2020 · Journal of Parkinson s Disease
37. Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease
    Pablo Gracia, José D. Camino, Laura A. Volpicelli‐Daley, Nunilo Cremades · 2020 · International Journal of Molecular Sciences
38. ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
    Eva K. L. Nordström, Fredrik Eriksson, Jessica Sigvardson, Malin Johannesson, Alex Kasrayan, Martina Jones-Kostalla, Paulina Appelkvist, Linda Söderberg, Patrik Nygren, Magdalena Blom et al. · 2021 · Neurobiology of Disease
39. Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease
    Stylianos Ravanidis, Anastasia M. Bougea, Nikolaos Papagiannakis, Matina Maniati, Christos Koros, Athina‐Maria Simitsi, Maria Bozi, Ioanna Pachi, María Stamelou, George P. Paraskevas et al. · 2019 · Movement Disorders
40. Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials
    Jung Hwa Seo, Sung‐Rae Cho · 2012 · Yonsei Medical Journal
41. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration
    Javier María Peralta Ramos, Pablo Iribarren, Luc Bousset, Ronald Melki, Veerle Baekelandt, Anke Van der Perren · 2019 · Frontiers in Immunology
42. A myosin-7B–dependent endocytosis pathway mediates cellular entry of α-synuclein fibrils and polycation-bearing cargos
    Qi Zhang, Yue Xu, Juhyung Lee, Michal Jarník, Xufeng Wu, Juan S. Bonifacino, Jingshi Shen, Yihong Ye · 2020 · Proceedings of the National Academy of Sciences
43. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
    Yuan Guan, Xiaofang Zhao, Fengwei Liu, Shuxin Yan, Yalong Wang, Cuilian Du, Xiuyu Cui, Rena Li, Claire Xi Zhang · 2020 · Frontiers in Cellular Neuroscience
44. Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
    Insup Choi, George R. Heaton, You-Kyung Lee, Zhenyu Yue · 2022 · Science Advances
45. Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?
    Philip C. Buttery, Roger A. Barker · 2014 · The Journal of Comparative Neurology
46. Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning
    Anne M.K. Schwerk, Jennifer Altschüler, Manfred Roch, Manfred Gossen, Christine Winter, Jürgen Berg, Armin Kurtz, Barbara Steiner · 2014 · Cytotherapy
47. Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts
    Fiorella Malchiodi‐Albedi, Silvia Paradisi, Andrea Matteucci, Claudio Frank, Marco Diociaiuti · 2011 · International Journal of Alzheimer s Disease
48. Lack of functional relevance of isolated cell damage in transplants of Parkinson’s disease patients
    Oliver Cooper, Arnar Astradsson, Penelope J. Hallett, H.A. Robertson, Ivar M. Mendez, Ole Isacson A · 2009 · Journal of Neurology
49. Future of Cell and Gene Therapies for Parkinson’s Disease
    O. Isacson, J. Kordower · 2008 · Annals of Neurology
50. The Gut and Nonmotor Symptoms in Parkinson's Disease
    Lisa Klingelhoefer, Heinz Reichmann · 2017 · International review of neurobiology
51. Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice
    Nicolas Naudet, Emilie Antier, Damien Gaillard, Eric Morignat, Latifa Lakhdar, Thierry Baron, Anna A. Bencsik · 2017 · Journal of Neuropathology & Experimental Neurology
52. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
    Tingting Zheng, Zhengxiang Zhang · 2021 · Neurochemistry International
53. Prion Diseases
    Boon Lead Tee, Erika Mariana Longoria-Ibarrola, Michael D. Geschwind · 2018 · Neurologic Clinics
54. Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke
    Rawan M. Tarawneh, James E. Galvin · 2010 · Clinics in Geriatric Medicine
55. Prion-Like Characteristics of Polyglutamine-Containing Proteins
    Margaret M.P. Pearce, Ron R. Kopito · 2017 · Cold Spring Harbor Perspectives in Medicine
56. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
    Paula Perez‐Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld · 2017 · Current Behavioral Neuroscience Reports
57. Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
    Albert Y. Hung, Michael A. Schwarzschild · 2020 · Neurotherapeutics
58. Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
    Wu, Shenjie, Hernandez Villegas, Nancy C, Sirkis, Daniel W, Thomas-Wright, Iona, Wade-Martins, Richard, Schekman, Randy · 2023 · eLife
59. Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
    Grace Kuo, Ramhari Kumbhar, William Blair, Valina Lynn Dawson, Ted M. Dawson, Xiaobo Mao · 2025 · Molecular Neurodegeneration
60. Emergence and natural selection of drug-resistant prions
    James Shorter · 2010 · Molecular BioSystems
61. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders
    Lina Patterson, Steven Rushton, Johannes Attems, Alan J. Thomas, Christopher M. Morris · 2018 · Brain Pathology
62. Neurons and Glia Interplay in α-Synucleinopathies
    Panagiota Mavroeidi, Maria Xilouri · 2021 · International Journal of Molecular Sciences
63. Cell transplantation and gene therapy in Parkinson's disease.
    D. R. Wakeman, Hemraj B. Dodiya, J. Kordower · 2011 · The Mount Sinai journal of medicine, New York
64. New hopes for disease modification in Parkinson's Disease
    Werner H Poewe, Klaus Seppi, Kathrin Marini, Philipp Mahlknecht · 2020 · Neuropharmacology
65. Fibrillar α-synuclein toxicity depends on functional lysosomes
    Stephanie J. Guiney, Paul Anthony Adlard, Peng Lei, Celeste Mawal, Ashley Ian Bush, David Isaac Finkelstein, Scott Ayton · 2020 · Journal of Biological Chemistry
66. Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
    Rui Wang, Haigang Ren, Elena V. Kaznacheyeva, Xiaojun Lu, Guanghui Wang · 2022 · Neuroscience Bulletin
67. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease
    Sang Hyun Park, Chan Wook Park, Jang Hyeon Eom, Mi-Young Jo, Hye‐Jin Hur, Sung Kyoung Choi, Jae Souk Lee, Seung Taek Nam, Ki-Sang Jo, Young Woo Oh et al. · 2023 · Cell stem cell
68. Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain
    Ana M. Espinosa‐Oliva, Rocío Ruiz, Manuel Sarmiento Soto, Antonio Boza‐Serrano, Ana Isabel Rodriguez-Perez, María Angustias Roca-Ceballos, Juan García‐Revilla, Marti Santiago, Sébastien Serres, Vasiliki Economopoulus et al. · 2024 · Neuropathology and Applied Neurobiology
69. α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies
    Claudio A. Soto · 2024 · Trends in biotechnology
70. Neuropathology in transplants in Parkinson's disease
    Patrik Brundin, Jeffrey H. Kordower · 2012 · Progress in brain research
71. Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
    Francisco J. Pan-Montojo, Heinz Reichmann · 2014 · Translational Neurodegeneration
72. A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol
    Christoph Gerdes, Natalia Waal, Thomas Offner, Eugenio F. Fornasiero, Nora Wender, Hannes Verbarg, Ivan Manzini, Claudia Trenkwalder, Brit Mollenhauer, Timo Strohäker et al. · 2020 · Nature Communications
73. Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases
    Adamantios Mamais, Meera Raja, Claudia Manzoni, Sybille Dihanich, Andrew John Lees, Darren J. Moore, Patrick Alfryn Lewis, Rina Bandopadhyay · 2013 · Neurobiology of Disease
74. Prions: Beyond a Single Protein
    Alvin S. Das, Wen‐Quan Zou · 2016 · Clinical Microbiology Reviews
75. Contributions of VPS35 Mutations to Parkinson’s Disease
    Abir A. Rahman, Brad E. Morrison · 2019 · Neuroscience
76. Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing
    Diego Pérez‐Rodríguez, Maria Kalyva, Melissa Leija‐Salazar, Tammaryn Lashley, Maxime Tarabichi, Viorica Chelban, Steve Gentleman, Lucía Schottlaender, Hannah Franklin, George Vasmatzis et al. · 2019 · Acta Neuropathologica Communications
77. Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients
    Teresia M. Osborn, Penelope J. Hallett, James M. Schumacher, Ole Isacson A · 2020 · Frontiers in Cellular Neuroscience
78. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
    Yabuki, Yasushi, Matsuo, Kazuya, Kawahata, Ichiro, Fukui, Naoya, Mizobata, Tomohiro, Kawata, Yasushi, Owada, Yuji, Shioda, Norifumi, Fukunaga, Kohji · 2020 · International Journal of Molecular Sciences
79. Neuropathology of α‐synuclein in Parkinson's disease
    Chi‐Jing Choong, Hideki Mochizuki · 2022 · Neuropathology
80. Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad
    Kreesan Reddy, Birger Victor Dieriks · 2022 · Molecular Neurodegeneration
81. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease
    Toru Yasuda, Hideki Mochizuki · 2010 · APOPTOSIS
82. Defining the limits: Protein aggregation and toxicityin vivo
    William M. Holmes, Courtney L. Klaips, Tricia R. Serio · 2014 · Critical Reviews in Biochemistry and Molecular Biology
83. An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain
    C. Pacheco, Luis Gerardo Aguayo, Carlos Opazo · 2012 · Frontiers in Physiology
84. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies
    Maria Graciela Cersosimo · 2017 · Cell and Tissue Research
85. Peptide-Imprinted Poly(hydroxymethyl 3,4-ethylenedioxythiophene) Nanotubes for Detection of α Synuclein in Human Brain Organoids
    Mei‐Hwa Lee, Kuan-Ting Liu, James Lawrence Thomas, Zi-Lin Su, Danny O’Hare, Thea van Wuellen, Jennifer Modamio, Silvia Bolognin, Shyh‐Chyang Luo, Jens Christian Schwamborn et al. · 2020 · ACS Applied Nano Materials
86. Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
    Emil Gregersen, Cristine Betzer, Woojin Scott Kim, Gergő E. Kovács, Lasse Reimer, Glenda Margaret Halliday, Steffen Thiel, Poul Henning Jensen · 2021 · Journal of Neuroinflammation
87. α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders
    Taku Hatano, Ayami Okuzumi, Gen Matsumoto, Taiji Tsunemi, Nobutaka Hattori · 2024 · Journal of Movement Disorders
88. Alpha Synuclein in Parkinson’s Disease
    Christine Lund Kragh, Marina Romero‐Ramos, Glenda Margaret Halliday, Poul Henning Jensen · 2014 · Springer eBooks
89. Neural grafts in Huntington's disease: viability after 10 years
    Anne‐Catherine Bachoud‐Lévi · 2009 · The Lancet Neurology
90. Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
    Chavarría, Cecilia, Ivagnes, Rodrigo, Souza, José M. · 2022 · Biomolecules
91. Current therapeutic strategies in Parkinson’s disease: Future perspectives
    Tae Young Kim, Byoung Dae Lee · 2025 · Molecules and Cells
92. Current Concepts of Neurodegenerative Diseases
    Gábor Géza Kovács · 2014 · EMJ Neurology
93. Cofilin 1 activation prevents the defects in axon elongation and guidance induced by extracellular alpha-synuclein
    Sharada M. Tilve, Francesco Difato, Evelina Chieregatti · 2015 · Scientific Reports
94. Structural basis for the dissociation of α-synuclein fibrils triggered by pressure perturbation of the hydrophobic core
    Guilherme A. P. de Oliveira, Mayra A. Marques, Carolina Cruzeiro-Silva, Yraima Cordeiro, Caroline Mello Pimentel Schuabb, Adolfo Henrique Moraes, Roland Winter, Hartmut Oschkinat, Débora Foguel, Mônica Santos de Freitas et al. · 2016 · Scientific Reports
95. Alpha-synuclein and iron: two keys unlocking Parkinson’s disease
    Paul Lingor, Eleonora Carboni, Jan Christoph Koch · 2017 · Journal of Neural Transmission
96. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
    Brendan B. McAllister, Sean G. Lacoursiere, Robert J. Sutherland, Majid H. Mohajerani · 2020 · Neuroscience & Biobehavioral Reviews
97. Super-resolution imaging reveals α-synuclein seeded aggregation in SH-SY5Y cells
    Jason C. Sang, Eric Hidari, Georg Meisl, Rohan T. Ranasinghe, Maria Grazia Spillantini, David Klenerman · 2021 · Communications Biology
98. TDP-43 Prions
    Takashi Nonaka, Masato Hasegawa · 2017 · Cold Spring Harbor Perspectives in Medicine
99. The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders
    Malfertheiner, Katja, Stefanova, Nadia, Heras-Garvin, Antonio · 2021 · Frontiers in Neurology
100. Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease
     Amanda Li, Joel Tyson, S.G. Patel, Meer Patel, Sruthi Katakam, Xiaobo Mao, Weiwei He · 2021 · Frontiers in Bioengineering and Biotechnology